Terumo (OTCMKTS:TRUMY) Shares Gap Up - Time to Buy?

Key Points

• Terumo Corp. shares experienced a significant price change, opening at $18.04 after closing at $17.13, with the most recent trade at $17.30 on a volume of 27,957 shares.
• The company reported earnings of $0.20 per share in its latest quarter, exceeding analysts' expectations by $0.03, although it fell short on revenue with $1.76 billion against estimates of $1.80 billion.
• Terumo has a low debt-to-equity ratio of 0.07 and a solid market capitalization of $25.61 billion, indicating financial stability.

Terumo Corp. (OTCMKTS:TRUMY - Get Free Report)'s share price gapped up prior to trading on Wednesday . The stock had previously closed at $17.13, but opened at $18.04. Terumo shares last traded at $17.30, with a volume of 27,957 shares traded.

Terumo Price Performance

The business's 50 day moving average is $17.62 and its two-hundred day moving average is $18.18. The firm has a market capitalization of $24.59 billion, a PE ratio of 29.14 and a beta of 0.79. The company has a debt-to-equity ratio of 0.07, a current ratio of 2.64 and a quick ratio of 1.53.

Terumo (OTCMKTS:TRUMY - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.20 EPS for the quarter, beating analysts' consensus estimates of $0.17 by $0.03. Terumo had a net margin of 12.09% and a return on equity of 9.19%. The business had revenue of $1.76 billion for the quarter, compared to analysts' expectations of $1.80 billion.

Terumo Company Profile

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.